Infographic

Navigating the Regulatory Crossroads of Drug, Device, and Biologic

Download PDF
Navigating the Regulatory Crossroads of Drug, Device, and Biologic, Syner-G

What Is a Combination Product?

As innovation merges drugs, biologics, and devices into single therapies, traditional regulatory boundaries continue to blur. While combination products improve patient convenience—such as enabling at-home self-administration—they also introduce greater regulatory complexity because each constituent part retains its individual regulatory status after combination.

The Three Types of Combination Products

  • Single-Entity Combination Products – Two or more regulated components are physically, chemically, or otherwise combined and produced as one unit.
  • Co-Packaged Combination Products – Two or more separate products packaged together in a single package or sold as a unit.
  • Cross-Labeled Combination Products – A drug, device, or biologic packaged separately but intended for use only with another specifically identified product.

Download PDF to Learn More

Share

Related Resources

All Resources

Let's move from science to success.

Let’s Talk